By Raluca Baciu, Vias Digital. Published 17 November 2026.
Last updated: 17 November 2026
Selling into healthcare is slow for good reasons. A clinician wants evidence, a hospital buyer wants proof of value and safety, and the company's own reviewers want every claim checked. Content that ignores any of them does not get read, or does not get approved.
This guide is about B2B healthcare: companies that sell diagnostics, software, services or equipment to providers and health systems. It is not about patient marketing. It covers what a healthcare content marketing agency should deliver, how claims review fits the workflow, and how to choose one.
Vias Digital is an executive thought leadership and strategic communications agency for established B2B companies in Europe and the United States. Our founder, Raluca Baciu, has done this work herself: at a Swiss-American health tech company she grew organic traffic by 36%.
Usually several people at the same customer, each with a different question.
Clinicians and lab leaders. Does it work, for which patients or samples, and what is the evidence?
Hospital and health system managers. What does it change in our workflow, our staff time and our results?
Procurement and IT. Is it safe, compliant, compatible with our systems and supported over time?
Executives. Why this, why now, and why this vendor?
A content plan should name which of these readers each piece is for.
In healthcare, your company's own medical, legal and regulatory reviewers decide what can be said. A good agency does not try to work around them. It makes their job easier.
Agree the rules before writing. Which claims are approved, which sources may be cited, which words to avoid, and who signs off.
Write with references in place. Every factual statement carries its source in the draft, so reviewers check rather than search.
Keep a library of approved wording. Once a claim is approved, reuse it word for word. It saves review rounds.
Plan review time into the calendar. Content that has to be approved cannot be produced the day before it goes live.
We make no medical claims of our own. The agency writes; your reviewers decide.
Content that respects a clinical reader's time and a buyer's need for proof.
| Content | Main reader | What it does |
|---|---|---|
Evidence summaries | Clinicians, lab leaders | Make published evidence easy to find and read, with references |
Workflow and value pages | Managers, executives | Explain what changes in daily work and outcomes |
Buyer guides | Procurement, IT | Answer the questions a tender or evaluation will ask |
Leader articles | Executives, the wider market | Give your company a credible point of view on where care is going |
Customer stories | All | Show results your customers have approved in writing |
Healthcare buyers trust people with experience. A chief medical officer explaining a clinical choice, or a founder explaining why a problem matters, reaches clinicians and executives in a way brand copy cannot. These pieces need the same claims review as everything else, and they need to sound like the person who signs them.
That is the core of executive thought leadership: your leaders' real views, written up in their voice, approved by them and by your reviewers.
Question 1: Have you worked inside a regulated review process? Ask how they prepare drafts for medical, legal and regulatory review, and how many rounds they usually need.
Question 2: Who writes, and can they read a study? Writers do not need to be clinicians, but they must understand evidence and know when to ask your experts.
Question 3: How do you keep claims consistent? Look for an approved-wording library and a habit of citing sources in every draft.
Question 4: Which readers does your plan serve? A plan that names clinicians, managers, procurement and executives separately understands the market.
Question 5: How will you measure success? Meetings, evaluations and pipeline touched by content, alongside search and traffic for the pages that matter.
The labels overlap. Healthcare content usually means selling to providers and health systems. Life science covers research, biotech and pharma buyers; see our life science marketing agency guide. Medtech covers devices and equipment with their own regulatory path; see our medtech marketing agency guide. Choose the agency whose experience matches the buyer you sell to.
If you need senior marketing leadership across all of it, a fractional CMO may be the better first step.
Start with the review process, not the calendar. Sit down with your medical, legal and regulatory reviewers, agree the approved claims and sources, and decide who signs off and how fast. Then pick the two or three pieces buyers use most in an evaluation, usually a buyer guide, a short evidence summary and a leader article, and write them first.
Share each finished piece with your sales and medical affairs teams so they can use it in real conversations. Add customer stories as customers approve them in writing. Review every quarter: which pieces helped deals move, which slowed review, and what to write next.
We start with the buyers and the approved claims, interview your clinical and business leaders, and write content that your reviewers can approve quickly: evidence summaries, buyer guides, leader articles and newsletters, all with sources in place. Your reviewers keep the final word.
Related guides: the content marketing agency overview, B2B content marketing agency, content marketing strategy agency, SEO content marketing agency and SaaS content marketing agency.
Tell us who you sell to and how your content is reviewed today. In one call we look at where content helps your sales cycle, where review slows it down and what to change first. You leave with a clear next step, whether or not we work together.
Content marketing agency, what a content marketing agency does for a B2B company, and how to choose one.
B2B content marketing agency, content that sells to a buying committee.
Content marketing strategy agency, when you need the strategy before the production.
SEO content marketing agency, content that ranks in Google and is cited in AI answers.
SaaS and tech content marketing agency, technical buyers and long buying committees.
Executive thought leadership, the content only your leaders can write.
It plans and writes content for companies that sell to providers and health systems: evidence summaries, buyer guides, leader articles, customer stories and newsletters, prepared so your medical, legal and regulatory reviewers can approve them.
No. This guide is about B2B: selling to hospitals, clinicians, labs and health systems. Patient marketing has different readers, channels and rules.
Your company's own medical, legal and regulatory reviewers. The agency writes and prepares the draft with sources; your reviewers decide what can be said.
Agree the rules before writing, put references in every draft, reuse approved wording word for word, and plan review time into the calendar.
Not necessarily, but they must understand evidence and know when to ask your experts. Ask to see work on a clinical subject.
Usually a clear buyer guide for the evaluation, a short evidence summary and one or two leader articles on where care is going. Then customer stories as customers approve them.
Meetings, evaluations and pipeline that content touched, plus rankings and traffic for the pages buyers use to compare vendors. Long sales cycles need patience and consistent tracking.
One 20-minute call with us. We go through your story and your proof, and tell you where we would start.
You speak directly with us.